Geeta Kashyap Vemuganti

Last updated

Geeta Kashyap Vemuganti
A.P.J. Abdul Kalam giving away the National Award to Dr. Virender Singh Sangwan, Associate Director in the L. V Prasad Eye Institute, Hyderabad & Smt. Geeta K Vemuganti, Director, Ophthalmic Pathologic Service and Head.jpg
Geeta Kashyap along with V. S. Sangwan receiving the National Award from Abdul Kalam.
Born (1960-07-01) 1 July 1960 (age 64)
Telangana, India
Nationality Indian
Known forStudies in stem cell therapy
Awards
Scientific career
Fields
Institutions

Geeta Kashyap Vemuganti (born 1 July 1960) is an Indian ocular pathologist and the head of the department at the Ophthalmic Pathology Service and Stem Cell Laboratory of the L. V. Prasad Eye Institute (LVPEI). [1] She is also a dean and professor at the school of medical sciences of the University of Hyderabad. [2]

Contents

Vemuganti is reported to have done pioneering work in stem cell therapy [note 1] and was a member of the team led by V. S. Sangwan that developed a protocol for transplanting cultured stem cells for restoring vision in humans. [3] She is an elected fellow of the National Academy of Medical Sciences [4] and a recipient of the 2005 Chem Tech Foundation Award. [3] The Department of Biotechnology of the Government of India awarded her the National Bioscience Award for Career Development, one of the highest Indian science awards, for her contributions to biosciences in 2004. [5]

Selected bibliography

See also

Notes

  1. Please see Selected bibliography section

Related Research Articles

<span class="mw-page-title-main">Stem cell</span> Undifferentiated biological cells that can differentiate into specialized cells

In multicellular organisms, stem cells are undifferentiated or partially differentiated cells that can change into various types of cells and proliferate indefinitely to produce more of the same stem cell. They are the earliest type of cell in a cell lineage. They are found in both embryonic and adult organisms, but they have slightly different properties in each. They are usually distinguished from progenitor cells, which cannot divide indefinitely, and precursor or blast cells, which are usually committed to differentiating into one cell type.

<span class="mw-page-title-main">Cornea</span> Transparent front layer of the eye

The cornea is the transparent front part of the eye that covers the iris, pupil, and anterior chamber. Along with the anterior chamber and lens, the cornea refracts light, accounting for approximately two-thirds of the eye's total optical power. In humans, the refractive power of the cornea is approximately 43 dioptres. The cornea can be reshaped by surgical procedures such as LASIK.

<span class="mw-page-title-main">Sankara Nethralaya</span> Hospital in Chennai, Kolkata

Sankara Nethralaya is a non-profit missionary institution for ophthalmic care headquartered in Chennai, India.

<i>Acanthamoeba</i> keratitis Eye infection caused by a protist

Acanthamoeba keratitis (AK) is a rare disease in which amoebae of the genus Acanthamoeba invade the clear portion of the front (cornea) of the eye. It affects roughly 100 people in the United States each year. Acanthamoeba are protozoa found nearly ubiquitously in soil and water and can cause infections of the skin, eyes, and central nervous system.

<span class="mw-page-title-main">Corneal neovascularization</span> Medical condition

Corneal neovascularization (CNV) is the in-growth of new blood vessels from the pericorneal plexus into avascular corneal tissue as a result of oxygen deprivation. Maintaining avascularity of the corneal stroma is an important aspect of healthy corneal physiology as it is required for corneal transparency and optimal vision. A decrease in corneal transparency causes visual acuity deterioration. Corneal tissue is avascular in nature and the presence of vascularization, which can be deep or superficial, is always pathologically related.

<span class="mw-page-title-main">Macular corneal dystrophy</span> Medical condition

Macular corneal dystrophy, also known as Fehr corneal dystrophy, is a rare pathological condition affecting the stroma of cornea first described by Arthur Groenouw in 1890. Signs are usually noticed in the first decade of life and progress afterwards, with opacities developing in the cornea and attacks of pain. This gradual opacification leads to visual impairment often requiring keratoplasty in the later decades of life.

<span class="mw-page-title-main">Boston keratoprosthesis</span> Prosthetic cornea

Boston keratoprosthesis is a collar button design keratoprosthesis or artificial cornea. It is composed of a front plate with a stem, which houses the optical portion of the device, a back plate and a titanium locking c-ring. It is available in type I and type II formats. The type I design is used much more frequently than the type II which is reserved for severe end stage dry eye conditions and is similar to the type I except it has a 2 mm anterior nub designed to penetrate through a tarsorrhaphy. The type I format will be discussed here as it is more commonly used.

<span class="mw-page-title-main">Herpes simplex keratitis</span> Medical condition

Herpetic simplex keratitis is a form of keratitis caused by recurrent herpes simplex virus (HSV) infection in the cornea.

Sheraz Daya is a British ophthalmologist. Daya founded the Centre for Sight in 1996, and works in stem-cell research and sight restoration and correction surgery.

<span class="mw-page-title-main">Reza Dana</span> American ophthalmologist and immunologist

Reza Dana is the Claes H. Dohlman Professor of Ophthalmology, senior scientist and W. Clement Stone Clinical Research Scholar at Massachusetts Eye and Ear, Harvard Medical School, and director of the Harvard-Vision Clinical Scientist Development Program.

Jeewan Singh Titiyal is an Indian ophthalmologist, credited with the first live cornea transplant surgery by an Indian doctor. He was honoured by the Government of India, in 2014, by bestowing on him the Padma Shri, the fourth highest civilian award, for his services to the field of medicine.

Mooren's ulcer is a rare idiopathic ocular disorder that may lead to blindness due to progressive destruction of the peripheral cornea. Although the etiology of Mooren's ulcer is poorly understood, recent evidence suggests that the pathogenesis of this disease appears to be the result of an autoimmune process directed against molecules expressed in the corneal stroma.

<span class="mw-page-title-main">Limbal stem cell</span>

Limbal stem cells, also known as corneal epithelial stem cells, are unipotent stem cells located in the basal epithelial layer of the corneal limbus. They form the border between the cornea and the sclera. Characteristics of limbal stem cells include a slow turnover rate, high proliferative potential, clonogenicity, expression of stem cell markers, as well as the ability to regenerate the entire corneal epithelium. Limbal stem cell proliferation has the role of maintaining the cornea; for example, by replacing cells that are lost via tears. Additionally, these cells also prevent the conjunctival epithelial cells from migrating onto the surface of the cornea.

<span class="mw-page-title-main">Vijay Anand Reddy</span> Indian oncologist (born 1959)

Dr. Vijay Anand Reddy is an Indian oncologist known for his contributions to the field of cancer. He serves as the director and senior consultant oncologist at Apollo Cancer Hospital, Hyderabad. He also served as the President of Association of Radiation Oncologists of India & Chairman of Indian College of Radiation Oncology.

<span class="mw-page-title-main">V. S. Sangwan</span> Indian ophthalmologist

Virender Singh Sangwan is an Indian ophthalmologist and the Dr. Paul Dubord Chair professor and director of the L. V. Prasad Eye Institute, Hyderabad. Known for his research on limbal stem cells, Sangwan is the founder secretary and an adviser of the Uveitis Society of India. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards for his contributions to Medical Sciences in 2006.

<span class="mw-page-title-main">M. Radhakrishna Pillai (scientist)</span> Indian cancer biologist

Madhavan Radhakrishna Pillai is an Indian cancer biologist and the former director of the Rajiv Gandhi Centre for Biotechnology. Known for his studies on papilloma viruses, Pillai is an elected fellow of the Indian Academy of Sciences, National Academy of Sciences, India, Royal College of Pathologists and the National Academy of Medical Sciences. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences in 2002.

Aditya Bhushan Pant is an Indian toxicologist, neurobiologist and a scientist at the Indian Institute of Toxicology Research. He is known for his studies in the fields of developmental toxicology, in vitro experiments as well as pesticides and is a member of the Neurobiology Task force of the Department of Biotechnology. His studies have been documented by way of a number of articles and ResearchGate, an online repository of scientific articles has listed 121 of them. Besides, he has contributed chapters to books published by others and is an associate editor of the Annals of Neurosciences journal of the Indian Academy of Neurosciences. He is a recipient for the Shakuntala Amir Chand Prize of the Indian Council of Medical Research in 2007. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences, in 2012.

<span class="mw-page-title-main">Graziella Pellegrini</span> Italian Professor of Cell Biology

Graziella Pellegrini is an Italian Professor of Cell Biology and the Cell Therapy Program Coordinator at the University of Modena and Reggio Emilia. She has developed and championed cell therapy protocols in hospitals across Italy.

Peripheral Ulcerative Keratitis (PUK) is a group of destructive inflammatory diseases involving the peripheral cornea in human eyes. The symptoms of PUK include pain, redness of the eyeball, photophobia, and decreased vision accompanied by distinctive signs of crescent-shaped damage of the cornea. The causes of this disease are broad, ranging from injuries, contamination of contact lenses, to association with other systemic conditions. PUK is associated with different ocular and systemic diseases. Mooren's ulcer is a common form of PUK. The majority of PUK is mediated by local or systemic immunological processes, which can lead to inflammation and eventually tissue damage. Standard PUK diagnostic test involves reviewing the medical history and a completing physical examinations. Two major treatments are the use of medications such as corticosteroids or other immunosuppressive agents and surgical resection of the conjunctiva. The prognosis of PUK is unclear with one study providing potential complications. PUK is a rare condition with an estimated incidence of 3 per million annually.

<span class="mw-page-title-main">Stem cell therapy for macular degeneration</span> Use of stem cells to treat macular degeneration

Stem cell therapy for macular degeneration is an emerging treatment approach aimed at restoring vision in individuals suffering from various forms of macular degeneration, particularly age-related macular degeneration (AMD). This therapy involves the transplantation of stem cells into the retina to replace damaged or lost retinal pigment epithelium (RPE) and photoreceptor cells, which are critical for central vision. Clinical trials have shown promise in stabilizing or improving visual function, but are nevertheless inefficient.

References

  1. "Scientists chosen for awards". The Hindu Business Line. 8 February 2005. Retrieved 16 December 2017.
  2. "PLENARY SESSIONS". www.caimsnmss.com. Archived from the original on 26 January 2018. Retrieved 16 December 2017.
  3. 1 2 "Breakthrough in stem cell transplantation of eye". The Hindu . 31 October 2001. Retrieved 16 December 2017.[ dead link ]
  4. "List of Fellows: October 2007" (PDF). National Academy of Medical Sciences. 2007. Retrieved 16 December 2017.
  5. "Awardees of National Bioscience Awards for Career Development" (PDF). Department of Biotechnology. 2016. Archived from the original (PDF) on 4 March 2018. Retrieved 20 November 2017.

Further reading